KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Treasury Shares (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Treasury Shares for 16 consecutive years, with $18.2 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Treasury Shares rose 20.54% year-over-year to $18.2 billion, compared with a TTM value of $18.2 billion through Sep 2024, up 20.54%, and an annual FY2023 reading of $15.1 billion, up 25.93% over the prior year.
  • Treasury Shares was $61.0 million for Q3 2024 at Thermo Fisher Scientific, roughly flat from $61.0 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $61.0 million in Q1 2024 and bottomed at $3.0 million in Q4 2022.
  • Average Treasury Shares over 5 years is $45.1 million, with a median of $48.0 million recorded in 2022.
  • The sharpest move saw Treasury Shares surged 52.33% in 2020, then increased 20.54% in 2024.
  • Year by year, Treasury Shares stood at $6.8 billion in 2020, then surged by 30.86% to $8.9 billion in 2021, then surged by 34.69% to $12.0 billion in 2022, then grew by 25.93% to $15.1 billion in 2023, then increased by 20.45% to $18.2 billion in 2024.
  • Business Quant data shows Treasury Shares for TMO at $18.2 billion in Q3 2024, $18.2 billion in Q2 2024, and $18.2 billion in Q1 2024.